Latest Commercialisation News

FBR Limited has secured a significant $7.8 million memorandum of understanding for its Hadrian X® robotic bricklayer and launched a new DST®-enabled welding robot, Mantis, while advancing automation projects with Samsung Heavy Industries.

BPH Global has transitioned from development to early commercial sales in its Indonesian seaweed operations, securing key offtake agreements and advancing multiple R&D projects. The company also raised $609,000 in fresh capital, positioning itself for growth in sustainable biotech markets.

Pro Medicus Limited has entered a strategic financing arrangement with 4DMedical to accelerate the development and commercialization of cutting-edge lung function imaging software.

Recce Pharmaceuticals advances its clinical pipeline with expanded Phase 3 trials in Indonesia and Australia, backed by a $15.8 million capital raise and a $30 million debt facility.

Redcastle Resources has reported a substantial 280% increase in its gold Mineral Resource Estimates at its Queen Alexandra and Redcastle Reef deposits, reaching a combined 42,000 ounces. The company also signed a strategic MoU with Terra Mining to accelerate mining operations with a low capital expenditure model.

ADX Energy reported a 23% rise in production to 303 BOEPD for Q2 2025, offsetting a 10% drop in Brent oil prices, while advancing key drilling plans and awaiting new permit awards.

Nanollose Limited has completed a successful pilot manufacturing run blending its Nullarbor-20 fibre with wool, raised $1.05 million through an entitlement issue, and appointed Andrew Moullin as CEO to drive its commercialisation strategy.

Tungsten Mining NL advances its Mt Mulgine project with a new gold extraction approach while reporting a maiden inferred resource at Hatches Creek, positioning itself strongly amid rising tungsten prices.

South Harz Potash Limited has bolstered its balance sheet through a combined A$2.39 million equity raise, positioning itself to pursue a dual-asset strategy targeting new critical minerals while preserving its core German potash project.

Emperor Energy has secured a significant upgrade to its Judith Gas Field resources following an independent audit, alongside a $3.7 million capital raise to fund the upcoming Judith-2 appraisal well scheduled for mid-2026.

Tryptamine Therapeutics has initiated the first-ever clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with patient dosing set to begin shortly and results expected by year-end.

Vectus Biosystems confirms safety of its lead fibrosis drug VB0004 from Phase Ia/Ib trials and advances licensing talks globally, including in China, while managing costs and funding challenges.